glutathione in ovarian cancer a double-edged sword Frontiers Targeting ferroptosis in ovarian cancer:
Description
NOD mice treated with MOTS-c showed a decreased abundance of Th1 cells and an increase in the abundance of Treg cells in the spleen and pancreas, which significantly delayed disease progression [8]
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma
In contrast to CDK4 amplifications, PKMYT 1 dependence demonstrates a need, some capacity, for regulated cell cycle in GBM to avoid excessive DNA damage accumulation
Effectiveness of fertility awareness-based methods for pregnancy prevention a systematic review
